Supplementary Data. Supplementary data related to this article can be found online at ▇▇▇▇://▇▇.▇▇▇.▇▇▇/10.1016/j.ejon.2013.03.004. ▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇▇▇, N., 2008. Literature review of methods to translate health-related quality of life questionnaires for use in multinational clinical trials. Value in Health 11 (3), 509e521. ▇▇▇▇▇▇▇▇, J., ▇▇▇▇▇▇▇, ▇.▇., 1988. Structural equation modeling in practice: a review and recommended two-step approach. Psychological Bulletin 103 (3), 411e423. ▇▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇-▇▇▇▇▇▇▇, ▇.▇., ▇▇▇▇▇▇▇, ▇.▇., ▇▇▇▇▇▇▇▇, E., ▇▇▇▇▇▇, B., ▇▇▇▇▇▇▇▇- ▇▇▇▇▇▇▇▇▇▇, ▇., et al., 2002. Standard versus intensified chemotherapy with granulocyte colony-stimulating factor support in small-cell lung cancer: a prospective European Organization for Research and Treatment of Cancer-Lung Cancer Group Phase III Trial-08923. Journal of Clinical Oncology 20 (19), 3947e 3955. ▇▇▇▇▇▇, ▇.▇., ▇▇▇▇, S.M., ▇▇▇▇▇, ▇., ▇▇▇▇▇▇, ▇., 2009a. Using the FACT-leukemia Subscale to Evaluate Quality of Life in Leukemia Patients Worldwide. In: Poster Presented at the 12th Annual Conference of the International Society for Pharmacoeconomics and Outcomes Research October 24e27, 2009, Paris, France. ▇▇▇▇▇▇, ▇.▇., ▇▇▇▇, S.M., ▇▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇, ▇., ▇▇▇▇▇, D., 2009b. Using the FACTlymphoma Subscale to Evaluate Quality of Life in Non-Hodgkin’s Lymphoma Patients from across the Globe. In: Poster Presented at the 16th Annual Conference of the International Society for Quality of Life Research, October 28e31, New Orleans, USA. ▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇, ▇., ▇▇▇▇▇▇▇▇▇, ▇.▇., ▇▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇▇▇, ▇.▇., ▇▇▇▇▇-▇▇▇▇▇, ▇.▇., et al., 2011. Clinical presentation and management of dermatological toxicities of epidermal growth factor receptor inhibitors. International Journal of Dermatology 50 (2), 129e146. ▇▇▇▇▇▇, ▇.▇., ▇▇▇▇▇, ▇.▇., ▇▇▇▇, ▇.▇., ▇▇▇▇▇▇▇, K., ▇▇▇▇▇▇▇-▇▇▇▇▇▇▇▇▇▇, B., ▇▇▇▇▇▇▇, ▇., et al., 1996. Multilingual translation of the Functional Assessment of Cancer Therapy (FACT) quality of life measurement system. Quality of Life Research 5 (3), 309e320. ▇▇▇▇, ▇., ▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇▇▇▇▇, A.R., ▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇, D., ▇▇▇▇▇▇▇, G.A., et al., 2005. Quality of life in lung cancer: the validity and cross-cultural applicability of the Functional Assessment of Cancer Therapy-Lung scale. Hematology/ Oncology Clinics of North America 19 (2), 389e420. viii. ▇▇▇▇▇, ▇.▇., 1994. Quality of life: concepts and definition. Journal of Pain and Symptom Management 9 (3), 186e192. ▇▇▇▇▇, D., ▇▇▇▇▇▇▇, K., 1997. Linking outcomes management to quality-of-life measurement. Oncology 11 (11A), 232e235. ▇▇▇▇▇, A.M., ▇▇▇▇, ▇.▇., ▇▇▇▇▇▇▇, ▇., 1999. Translation of questionnaires and issues of equivalence. Journal of Advanced Nursing 29 (2), 316e322. ▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇▇, P., ▇▇▇▇▇▇▇, P., ▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇▇▇, N., 2002. Patient reported outcomes and regulatory issues: the example of health-related quality of life - a European guidance document for the improved integration of HRQL assessment in the drug regulatory process. Drug Information Journal 36 (1), 209e238. ▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇, L., ▇▇▇▇▇, D., 2004. Development and multilingual validation of the fact-lymphoma instrument. Quality of Life Research 13 (9), 1501. ▇▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇▇, ▇., ▇▇▇▇▇▇, B., ▇▇▇▇▇, D., 2005a. Multilingual validation of the Fact-Leukemia in 5 languages. Quality of Life Research 14 (9), 1991. ▇▇▇▇▇▇▇▇, ▇.▇., ▇▇▇▇▇, D., ▇▇▇▇▇▇, ▇.▇., 2005b. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Evaluation & the Health Professions 28 (2), 212e232. European Commission, 2006. Special Eurobarometer 243: Europeans and Their Languages (Survey). Available at: ▇▇▇▇://▇▇.▇▇▇▇▇▇.▇▇/public_opinion/archives/ebs/ebs_243_en.pdf (accessed 02.10.12.). ▇▇▇▇▇.▇▇▇., 2010. Functional Assessment of Chronic Illness Therapy (FACIT). Available at: ▇▇▇▇://▇▇▇.▇▇▇▇▇.▇▇▇/FACITOrg/Questionnaires (accessed 31.05.11.).
Appears in 2 contracts
Sources: Not Applicable (Or Unknown), Not Applicable (Or Unknown)